4b1827 | Danisco (UK) Ltd, trading as Danisco Animal Nutrition and represented by Genencor International B.V., | Bacillus amyloliquefaciens PTA-6507, Bacillus amyloliquefaciens NRRLB-50013 and Bacillus amyloliquefaciens NRRL B-50104 | Additive compositionPreparation of Bacillus amyloliquefaciens PTA-6507, Bacillus amyloliquefaciens NRRLB-50013 and Bacillus amyloliquefaciens NRRL B-50104 containing a minimum of 2,5 × 109 CFU/g (total) with a minimum of bacterial concentration of 8,3 × 108 of each strain/g additive.Solid formCharacterisation of the active substanceViable spores of Bacillus amyloliquefaciens PTA-6507, Bacillus amyloliquefaciens NRRLB-50013 and Bacillus amyloliquefaciens NRRL B-50104Analytical methodIdentification and enumeration of Bacillus amyloliquefaciens PTA-6507, Bacillus amyloliquefaciens NRRLB-50013 and Bacillus amyloliquefaciens NRRL B-50104 in the feed additive, premixtures and feedingstuffs- Identification: Pulsed Field Gel Electrophoresis (PFGE)
- Enumeration: Spread plate method following heat treatment — EN 15784
| Chickens for fatteningChickens reared for layingMinor poultry species for fattening and reared for laying | — | 7,5 × 107 | — | 1.In the directions for use of the additive and premixture, indicate the storage temperature, storage life and stability to pelleting.2.The use is compatible in feed containing the following authorised coccidiostats: narasin/nicarbazin, maduramicin ammonium, lasalocid A sodium, salinomycin sodium, monensin sodium, robenidine hydrochloride, diclazuril, decoquinate, semduramycin sodium or nicarbazin.3.For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from its use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment. | 3 April 2027 |